1. Home
  2. BMRN vs TKO Comparison

BMRN vs TKO Comparison

Compare BMRN & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • TKO
  • Stock Information
  • Founded
  • BMRN 1996
  • TKO 1980
  • Country
  • BMRN United States
  • TKO United States
  • Employees
  • BMRN N/A
  • TKO N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • TKO
  • Sector
  • BMRN Health Care
  • TKO
  • Exchange
  • BMRN Nasdaq
  • TKO Nasdaq
  • Market Cap
  • BMRN 13.7B
  • TKO 13.1B
  • IPO Year
  • BMRN 1999
  • TKO N/A
  • Fundamental
  • Price
  • BMRN $59.17
  • TKO $149.22
  • Analyst Decision
  • BMRN Buy
  • TKO Strong Buy
  • Analyst Count
  • BMRN 22
  • TKO 15
  • Target Price
  • BMRN $94.00
  • TKO $153.21
  • AVG Volume (30 Days)
  • BMRN 2.0M
  • TKO 2.3M
  • Earning Date
  • BMRN 05-01-2025
  • TKO 05-08-2025
  • Dividend Yield
  • BMRN N/A
  • TKO 1.02%
  • EPS Growth
  • BMRN 153.71
  • TKO N/A
  • EPS
  • BMRN 2.21
  • TKO 0.02
  • Revenue
  • BMRN $2,853,915,000.00
  • TKO $2,804,341,000.00
  • Revenue This Year
  • BMRN $12.23
  • TKO $57.97
  • Revenue Next Year
  • BMRN $9.93
  • TKO $21.42
  • P/E Ratio
  • BMRN $26.81
  • TKO $2,714.93
  • Revenue Growth
  • BMRN 17.97
  • TKO 67.43
  • 52 Week Low
  • BMRN $52.93
  • TKO $94.32
  • 52 Week High
  • BMRN $94.85
  • TKO $179.09
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 37.64
  • TKO 50.60
  • Support Level
  • BMRN $52.93
  • TKO $146.34
  • Resistance Level
  • BMRN $60.93
  • TKO $150.86
  • Average True Range (ATR)
  • BMRN 3.18
  • TKO 6.83
  • MACD
  • BMRN -0.53
  • TKO 0.37
  • Stochastic Oscillator
  • BMRN 34.01
  • TKO 62.28

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a premium sports and entertainment company that comprises UFC, the world's mixed martial arts organization, and WWE, an integrated media organization and the recognized leader in sports entertainment.

Share on Social Networks: